• AML with Recurrent Genetic Abnormalities
• AML with Myelodysplasia-Related Changes
• Therapy-Related Myeloid Neoplasms
• Acute Myeloid Leukemia, NOS (AML-NOS)
• Myeloid Sarcoma
• Myeloid Proliferations Related to Down-Syndrome
• Blastic Plasmacytoid Dendritic Cell Neoplasm

References

Swerdlow SH, Campo E, Harris, NL, Jaffe ES, Pileri SA, Stein H, Thiele J (Eds):  WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (Revised 4th edition). IARC: Lyon 2017